-
Preclinical Data Show Promise for Diabetic Eye Drug
Early evidence shows a drug designed as eye drops to treat diabetic macular edema, an eye disease in people with diabetes, permeates the entire eye, including the retina.
-
Immune Disease Start-Up Raises $28M in Early Funds
A new company founded to develop treatments for diseases caused by problems with the immune system is raising $28.4 million in its first round of financing.
-
Algorithm Quickly Customizes Walking Exoskeleton
Researchers at Carnegie Mellon University in Pittsburgh wrote and tested an algorithm for exoskeletons that customize the devices to a person’s walking pattern in about an hour.
-
Long-Acting Drug Blocks Opioid Effects, Withdrawal
Findings from a clinical trial show a formulation of the drug buprenorphine given once a week blocks effects of subsequent opioid exposure and withdrawal symptoms.
-
Computer-Designed Antibodies Target Alzheimer’s Proteins
Researchers in Europe designed antibodies, like those in the immune system, to attack protein deposits in the brain associated with Alzheimer’s disease.
-
Commercial-Scale Flu Vaccine Produced in Cell Cultures
A vaccine developer says it produced large quantities of a current influenza vaccine for distribution to clinics and hospitals, grown in animal cell cultures rather than eggs.
-
Organ Chips to be Studied on Space Station
A range of biological functions will be assessed with model organs on plastic chips in a series of experiments on the International Space Station.
-
FDA Approves Skin Infection Drug
The U.S. Food and Drug Administration approved a new drug that treats serious bacterial skin infections, including those often resistant to current antibiotics.
-
Engineered Algae Doubles Bio-Oil Content
An industry biotechnology team created a genetically-engineered variety of algae that doubles its oil content without limiting its ability to grow.
-
Exosuit Prototype Unveiled for Stroke Survivors
An assistive device with sensors and motors designed to help people with stroke and other muscle disorders walk more normally was demonstrated on 16 June.